RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 115 filers reported holding RELAY THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $748,456 | -49.7% | 88,996 | -24.9% | 0.00% | 0.0% |
| Q2 2023 | $1,489,227 | +11.0% | 118,569 | +45.6% | 0.00% | 0.0% |
| Q1 2023 | $1,341,680 | +18.0% | 81,462 | +7.0% | 0.00% | 0.0% |
| Q4 2022 | $1,137,173 | -21.2% | 76,116 | +18.0% | 0.00% | -50.0% |
| Q3 2022 | $1,443,000 | +48.6% | 64,508 | +11.2% | 0.00% | +100.0% |
| Q2 2022 | $971,000 | -1.6% | 58,011 | +75.9% | 0.00% | 0.0% |
| Q1 2022 | $987,000 | +6.4% | 32,978 | +9.1% | 0.00% | – |
| Q4 2021 | $928,000 | -10.4% | 30,218 | -8.0% | 0.00% | -100.0% |
| Q3 2021 | $1,036,000 | -16.4% | 32,861 | -2.9% | 0.00% | 0.0% |
| Q2 2021 | $1,239,000 | +22.3% | 33,835 | +15.4% | 0.00% | 0.0% |
| Q1 2021 | $1,013,000 | -52.4% | 29,314 | -42.8% | 0.00% | 0.0% |
| Q4 2020 | $2,128,000 | – | 51,223 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 10,551,115 | $438,504,000 | 37.66% |
| TRV GP IV, LLC | 2,811,197 | $116,833,000 | 37.48% |
| Foresite Capital Management V, LLC | 400,000 | $16,624,000 | 12.31% |
| Foresite Capital Management IV, LLC | 2,139,380 | $88,913,000 | 9.66% |
| EcoR1 Capital, LLC | 3,200,649 | $133,019,000 | 7.15% |
| BVF INC/IL | 3,073,147 | $127,720,000 | 5.02% |
| Casdin Capital, LLC | 3,808,894 | $158,298,000 | 4.69% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $1,159,730,000 | 4.67% |
| Grace Capital | 164,389 | $6,832,000 | 4.32% |
| Alphabet Inc. | 1,801,490 | $74,870,000 | 3.59% |